Zobrazeno 1 - 10
of 42
pro vyhledávání: '"Fengkuan Yu"'
Autor:
Yingling Zu, Ruirui Gui, Zhen Li, Juan Wang, Yanli Zhang, Fengkuan Yu, Huifang Zhao, Xinrong Zhan, Zhongliang Wang, Pengtao Xing, Xianjing Wang, Huili Wang, Yongping Song, Jian Zhou
Publikováno v:
Blood Cancer Journal, Vol 13, Iss 1, Pp 1-4 (2023)
Externí odkaz:
https://doaj.org/article/45f1047320724dd08b1f8cf45a664e4a
Autor:
Zhen Li, Binglei Zhang, Xinxin Fan, Ruirui Gui, Fengkuan Yu, Juan Wang, Yanli Zhang, Keshu Zhou, Yanyan Liu, Yufu Li, Jing Ding, Yongping Song, Jian Zhou
Publikováno v:
Frontiers in Oncology, Vol 13 (2023)
BackgroundHematopoietic stem cell transplantation (HSCT) is an important treatment for T-cell lymphoblastic lymphoma/leukemia (T-LBL). To compare the efficacy and influencing factors of autologous hematopoietic stem cell transplantation (auto-HSCT) w
Externí odkaz:
https://doaj.org/article/00f5fb10df064087a8d3c6fb034f257c
Autor:
Zhenghua Huang, Zhen Li, Juan Wang, Ruirui Gui, Yingling Zu, Fengkuan Yu, Quande Lin, Huifang Zhao, Yanli Zhang, Baijun Fang, Yanyan Liu, Keshu Zhou, Yufu Li, Yuewen Fu, Zhihua Yao, Yongping Song, Jian Zhou
Publikováno v:
Frontiers in Oncology, Vol 13 (2023)
BackgroundWhether autologous hematopoietic stem cell transplantation (ASCT) improves the survival of patients with peripheral T-cell lymphoma (PTCL) remains controversial. Some studies have demonstrated that the efficacy of ASCT is superior in patien
Externí odkaz:
https://doaj.org/article/8053a24ad1f0496298eaa9357a9c34ca
Autor:
Binglei Zhang, Lingyun Chen, Jian Zhou, Yingling Zu, Ruirui Gui, Zhen Li, Juan Wang, Fengkuan Yu, Yanli Zhang, Huifang Zhao, Zhenyu Ji, Yongping Song
Publikováno v:
Scientific Reports, Vol 11, Iss 1, Pp 1-9 (2021)
Abstract This study aimed to observe the safety and clinical efficacy of early application of ruxolitinib to prevent acute graft-versus-host disease (aGVHD) after alternative donor transplantation in acute leukemia. There were 57 patients undergoing
Externí odkaz:
https://doaj.org/article/5eb65bd70e574ceb9712c6801b7e4352
Autor:
Yingling Zu, Jian Zhou, Yuewen Fu, Baijun Fang, Xinjian Liu, Yanli Zhang, Fengkuan Yu, Wenli Zuo, Hu Zhou, Ruirui Gui, Zhen Li, Yanyan Liu, Huifang Zhao, Chengjuan Zhang, Yongping Song
Publikováno v:
Scientific Reports, Vol 11, Iss 1, Pp 1-11 (2021)
Abstract Posttransplant cyclophosphamide (PTCy) as graft-versus-host disease (GVHD) prophylaxis is an effective strategie for patients receiving matched sibling donor hematopoietic stem cell transplantation (MSD-HSCT) and haploidentical HSCT (haplo-H
Externí odkaz:
https://doaj.org/article/724d8a01d0d94abd8790aa8930e381eb
Autor:
Binglei Zhang, Jian Zhou, Fengkuan Yu, Tianxin Lv, Baijun Fang, Dandan Fan, Zhenyu Ji, Yongping Song
Publikováno v:
Experimental Hematology & Oncology, Vol 9, Iss 1, Pp 1-11 (2020)
Abstract Background The high-risk refractory and/or relapsed (R/R) childhood acute leukemia prognosis is poor, and allogeneic stem cell transplantation (allo-HSCT) is the most prudent treatment modality. However, there are limited matched sibling don
Externí odkaz:
https://doaj.org/article/c1ba4567643948c5873428e50f896119
Autor:
Binglei Zhang, Jian Zhou, Ruirui Gui, Zhen Li, Yingling Zu, Juan Wang, Fengkuan Yu, Yanli Zhang, Huifang Zhao, Zhenyu Ji, Yongping Song
Publikováno v:
Frontiers in Cellular and Infection Microbiology, Vol 11 (2021)
Central nervous system (CNS) complications can occur in 9%–15% of patients after allogeneic hematopoietic stem cell transplantation (allo-HSCT). The clinical manifestations of the CNS complications are non-specific, with most of them being disturba
Externí odkaz:
https://doaj.org/article/f1ffa4b8071c4467b59e6dc7294ceaf4
Autor:
Yingling Zu, Zhen Li, Ruirui Gui, Yanyan Liu, Yanli Zhang, Fengkuan Yu, Huifang Zhao, Yuewen Fu, Xinrong Zhan, Zhongliang Wang, Pengtao Xing, Xianjing Wang, Huili Wang, Jian Zhou, Yongping Song
Publikováno v:
Bone marrow transplantation. 57(10)
The most widely used regimens of graft-versus-host disease (GVHD) prophylaxis in HLA-matched unrelated donor peripheral blood stem cell transplantation (MUD-PBSCT) are based on anti-thymocyte globulin (ATG) or post-transplant cyclophosphamide (PTCy).
Autor:
Zhen Li, Fengkuan Yu, Yongping Song, Huifang Zhao, Yingling Zu, Mojun Han, Jian Zhou, Ruirui Gui, Yanli Zhang
Publikováno v:
Transplantation Proceedings. 52:1860-1863
Allogeneic hematopoietic stem cell transplantation (allo-HSCT) is an effective measure for the treatment of severe aplastic anemia (SAA). While infection, graft failure, and graft-vs-host disease (GVHD) are the main causes of allo-HSCT failure, a sec
Autor:
Qing Zhang, Zhen Li, Yujie Hou, Huibing Dang, Jianling Chen, Lixin Liang, Qian Wang, Changsong Cao, Huifang Zhao, Ruirui Gui, Yingling Zu, Jian Zhou, Fengkuan Yu, Juan Wang, Yongping Song, Yanli Zhang
Publikováno v:
Annals of palliative medicine. 11(4)
The main objective of this study was to explore health-related quality of life (HRQoL) profiles, chronic disease management practices and key factors associated with HRQoL in 540 patients with chronic myeloid leukemia in chronic phase (CML-CP) admini